icon-account icon-glass
FREE PODCAST SERIES WITH DR. BILL CODE - CLICK HERE
Connect

MIRTAZAPINE WITHDRAWAL / HELP TAPERING OFF MIRTAZAPINE NATURALLY

mirtazapine withdrawal success video

Mirtazapine, like all antidepressants can cause a variety of severe symptoms when withdrawing due to a state of Serotonin dysregulation.  This is particularly true with a sudden withdrawal from Mirtazapine and the symptoms can be minimized by tapering off Mirtazapine gradually. [1]  Yet many find even a small dose reduction causes symptoms that interfere with every aspect of life.  This is why we implement both slowly tapering off Mirtazapine with a proven holistic approach to easing Mirtazapine withdrawal. Over the last 17 years our methodology has been implemented worldwide and can provide the best chance of success to get off Mirtazapine.*
    marks mirtazapine withdrawal success story

    Thank you God for directing my web fingers to Point of Return.

    by Mark (USA)

    SIGNS OF MIRTAZAPINE DEPENDENCE

    Mirtazapine is a tetracyclic antidepressant that alters both Serotonin and Norepinephrine and as the body adapts to Mirtazapine intradose symptoms can arise that include anxiety, interruption in sleep patterns, stomach upset and a myriad of distressing symptoms.  Mirtazapine has not been studied for its potential for tolerance or physical dependence [2] but our clients all reported similar symptoms of intradose withdrawals, an increase in anxiety and disturbance in their lives.*

     

    WHAT IS MIRTAZAPINE WITHDRAWAL LIKE? 

    Missing or reducing one dose of Mirtazapine can result in one or more of the following withdrawal symptoms:  irritability, dizziness, nightmares, nausea, headaches and paresthesias (tingling, prickling sensation on the skin). [3] Tapering off Mirtazapine slowly is essential, but after 17 years of helping people withdraw worldwide, we have found that many need consistent, safe relief from Mirtazapine Withdrawal. We implement a holistic approach to both minimize Mirtazapine Withdrawal symptoms and assist in the recovery of the receptors altered by the drug*

    I cannot say enough good things about the entire PONT OF RETURN team. I will be forever grateful.

    by Robin

    It was NO WAY as scary a process as I had built myself up to 'fear'. I'm delighted to have come off the medication and have felt much better as a result...clarity of thought, memory function and generally feeling 'normal' at last...after so many years. I hope this will help you make a more informed decision - take the risk...it's well worth it!

    Graham -  Mirtazapine Weaning Success Story

    SUCCESSFUL MIRTAZAPINE WITHDRAWAL HELP - HOW TO WEAN OFF MIRTAZAPINE NATURALLY AT HOME

     

    Our Mirtazapine At-Home Withdrawal Tapering Program combines a slow Mirtazapine taper with a powerful holistic approach to minimizing symptoms.  This allows you to step down gently from Mirtazapine under the close guidance of Our Team, Your Physician, and Pharmacist.  Our Pre-taper is necessary to help provide relief. You do not taper Mirtazapine until you are feeling better.  Our nonprofit has been helping people all over the world to escape Mirtazapine and antidepressants dependence for over 17 years.  You are not alone through the process.*

    Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis.  Our innovative approach to antidepressant tapering encompasses a holistic method to empower you on your path to recovery. Don't Wean Mirtazapine alone, work with us.*


    How to wean off Mirtazapine successfully with Point of Return

    MIRTAZAPINE WITHDRAWAL SYMPTOMS MAY INCLUDE


    • aggression
    • anxiety
    • balance issues 
    • blurred vision
    • brain zaps
    • concentration impairment
    • constipation
    • crying spells
    • depersonalization
    •  diarrhea
    •  dizziness
    • electric shock sensations
    • fatigue
    • flatulence
    •  flu-like symptoms
    •  hallucinations 
    • hostility
    • highly emotional
    • indigestion
    • impaired speech
    • infomnia
    • jumpy nerves
    • lack of coordination
    • leathargy
    • migraine headaches
    • increased headaches
    • nausea
    • nervousness
    • over-reacting to situations
    • paranoia
    • repetitive thoughts
    • sensory and sleep disturbances
    • severe internal restlessness
    • stomach cramps
    • temors, tinnitus or buzzing
    • tingling sensations
    • troubling thoughts
    • visual hallucinations
    • vivid dreams
    • speech or visual changes
    • worsened depression

    Thank You for Giving My Life Back to Me. I can now relax with my family and work properly. Hope this will inspire those still on their journey of healing.

    by Ewembe (South Africa) Antidepressant Withdrawal Success

    IMAGINE BEING FREE OF MIRTAZAPINE DEPENDENCY


     Proven Program completed At-Home

    ✔ Slowly Wean Off Mirtazapine

    ✔ All-Natural Nutraceuticals to help ease Mirtazapine Withdrawal*

    ✔ Professional information and support to empower you 

    ✔ Free Mentoring on our 24/7 private Discussion Board

    Enter Discount Code ADFree for FREE Ground Shipping on your Withdrawal Program (USA & Canada Only)

    MIRTAZAPINE WITHDRAWAL TIMELINE

    Mirtazapine withdrawal may be different for each person and while there is no exact timeline, the symptoms generally begin within 24 hours or missing or lowering a dose of Mirtazapine. [5] Clinical reports describe withdrawal symptoms of panic, anxiety, restlessness, irritability, insomnia, hypomania, nausea and vomiting after a decrease or discontinuation of Mirtazapine. Studies have shown that Mirtazapine withdrawal symptoms and syndromes may occur during and despite tapering off Mirtazapine slowly.

    Point of Return has implemented a powerful, proven, holistic approach to Mirtazapine Withdrawal over the past 17 years. We have found that utilizing calming supplements, eliminating any interaction item combined with a gradual taper provides the best chance to successfully taper off Mirtazapine.*

    I am so grateful for Point of Return and for all the support I have received to help me to taper from Zoloft, which I had been on for about 14 years. The almost immediate replies to emails and arrival of orders was humbling and the wonderful support of the POR team was a great help to me throughout the whole process. I found the slow-tapering programme to be both sensible and doable and have learned so much from undertaking the programme. Thank you so much to all at Point of Return. May God bless you!

    By Louise (Antidepressant Withdrawal Success)

    Is it Your Time to Start a New Journey?

    MIRTAZAPINE WITHDRAWAL SUCCESS STORIES

    vicky - mirtazapine Withdrawal Symptoms Success Story

    This experience has left me humbled and oh so grateful. Please let Point of Return work for you. They will provide the tools you need to succeed.  More...

    Vicky (Mirtazapine Withdrawal Success Story)

    trudee - how to wean off mirtazapine

    I owe it all to you, and everyone else at Point of Return. I am forever grateful, and I will never stop telling people about Point of Return. More...

    Trudee (Amitriptyline Withdrawal Success Story)

    mark tapering off mirtazapine

    I cannot say enough good things about the entire POR team. I will be forever grateful. Thank you from the bottom of my heart. More...

    Mark (Mirtazapine Withdrawal Success Story)

    HAVE QUESTIONS?

     

    Message sent, thanks! Will get back to your shortly.

    EXPERIENCE and TEAMWORK

    using a Natural Approach

    How long do Amitripytline Withdrawal Symptoms last with our team

    Our team has survived psychoactive drug withdrawal. More...

    how to wean off Amitripytline anywhere in the world

    We've helped people in 78 countries and in every state of the USA. More...

    Media about Amitripytline Withdrawal Symptoms and Help

    We have extensive media coverage; television, print, radio. More...   

    PROVEN RESULTS

    SIMPLE - NATURAL - EFFECTIVE

    MIRTAZAPINE RESOURCE CENTER

     

    MIRTAZAPINE WITHDRAWAL SYMPTOMS, SIDE EFFECTS AND ADVERSE REACTIONS ( link
    MIRTAZAPINE HISTORY AND INFO  ( link ) 
    MIRTAZAPINE REFERENCES AND FDA INFO ( link )
    MIRTAZAPINE WITHDRAWAL HELP (link)

      WHAT IS MIRTAZAPINE?

       

      A massive 2014 study of 22,610 people analyzed the affect on weight from the use of antidepressants. Mirtazapine (Remeron) was found to cause the greatest amount of weight gain, representing a 7% increase per year.There have been many reports of withdrawal symptoms upon the discontinuation of Mirtazapine or with a too rapid titration.

      The FDA states, "Patients currently taking Mirtazapine (Remeron) should NOT discontinue treatment abruptly, due to risk of discontinuation symptoms. At the time that a medical decision is made to discontinue treatment with Remeron (Mirtazapine), a gradual reduction in the dose, rather than an abrupt cessation, is recommended."

      Remeron (Mirtazapine) was introduced in the United States by the Dutch firm Organon International in 1996. Organon's first product was insulin in the 1920s and in the 30s they manufactured estrogens. Scherring-Plough Corporation acquired Organon in 2007, and in 2009 they was merged with Merck Pharmaceuticals. In October 2014 the U.S. government charged the manufacturer of Remeron with making improper financial incentives (kickbacks) to nursing homes to encourage the use of their drug. They were also charged with misrepresentation of drug prices and ordered to pay restitution for breaking the Federal Anti-Kickback Statute.

      Mirtazapine is known as a Tetracyclic antidepressant and classified as a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA), meaning Mirtazapine affects Norepinephrine and Serotonin.

      Mirtazapine increases the release of both Serotonin and to a lesser degree Norepinephrine (Noradrenaline). Norepinephrine increases blood pressure, affects parts of the brain where attention and action is controlled. Along with Epinephrine, Norepinephrine creates the fight-or-flight response that increases heart rate and triggers the release of glucose while increasing blood flow to the skeletal muscle. Serotonin influences the cardiovascular, renal, immune and gastrointestinal systems, and is essential to regulate body temperature, heart rate, blood pressure and the sympathetic nervous system. Mirtazapine is also a potent antihistamine that contributes to its sedative qualities but is also known to cause weight gain and sugar cravings.*

      top of page

      johnny - mirtazapine withdrawal

      “ I can't thank Point of Return enough and the best thing is knowing there are people out there like them.  That's what makes me happy.”

      — Johnny (Antidepressant Withdrawal Success)

      MIRTAZAPINE SIDE EFFECTS AND ADVERSE REACTIONS 

       

      MIRTAZAPINE SIDE EFFECTS MAY INCLUDE: 

      Abdominal pain, Chills, Fever, Face Edema, Ulcer, Neck rigidity, Neck pain, Chest pain, Hypertension, Angina, Migraine, Goiter, Hypothyroidism, Thirst or dehydration, Weight loss, Abnormal healing, Diabetes, Arthritis or bursitis, Anxiety, Agitation, Twitching, Hostility, Reflexes increased, Convulsions, Sinusitis, Cough increased, Rash, Acne, Urinary retention

      MIRTAZAPINE ADVERSE REACTIONS MAY INCLUDE: per PDR   

      Severe: cholecystitis, bronchospasm, bradycardia, myocardial infarction, exfoliative dermatitis, ocular hypertension, keratoconjunctivitis, hearing loss, muscle paralysis, seizures, GI obstruction, pancreatitis, cirrhosis, tendon rupture, bone fractures, asphyxia, pneumothorax, pulmonary embolism, heart failure, pancytopenia, serotonin syndrome, suicidal ideation, habdomyolysis, ventricular fibrillation, torsade de pointes, agranulocytosis, diabetic ketoacidosis, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis

      Moderate: hypercholesterolemia, constipation, hypertriglyceridemia, confusion, elevated hepatic enzymes, peripheral edema, hyperreflexia, delirium, dysarthria, ataxia, migraine, mania, hostility, hallucinations, depression, euphoria, dyskinesia, dystonic reaction, stomatitis, colitis, glossitis, dyspnea, angina, hypotension, dehydration, dysuria, hematuria, cystitis, urinary incontinence, impotence (erectile dysfunction), vaginitis, nephrolithiasis, urinary retention, hyperacusis, conjunctivitis, edema, aphasia, nystagmus, myoclonia, hypotonia, gastritis, oral ulceration, candidiasis, bone pain, phlebitis, lymphadenopathy, lymphocytosis, thrombocytopenia, leukopenia, anemia, gout, hyponatremia, diabetes mellitus, skin ulcer, ejaculation dysfunction, goiter, hypothyroidism, blepharitis, withdrawal, amnesia, myasthenia, peripheral vasodilation, hypertension, orthostatic hypotension, QT prolongation, neutropenia, hyperglycemia, bullous rash 

      Mild: drowsiness, weight gain, xerostomia, appetite stimulation, asthenia, dizziness, influenza, abnormal dreams, tremor, back pain, myalgia, increased urinary frequency, libido increase, emotional lability, paranoia, eructation, weight loss, nausea, epistaxis, syncope, fever, acne vulgaris, alopecia, xerosis, mastalgia, amenorrhea , dysmenorrhea, leukorrhea, otalgia, ocular pain, chills, headache, diplopia, tongue discoloration, hypersalivation, laryngitis, hiccups, petechiae, seborrhea, urticaria, polyuria, urinary urgency, breast enlargement, menorrhagia, parosmia, dysgeusia, paresthesias, hyperkinesis, hypoesthesia, vertigo, agitation, anxiety, abdominal pain, vomiting, anorexia, arthralgia, sinusitis, cough, polydipsia, rash, pruritus, photosensitivity, malaise, restlessness, infection* 

      MIRTAZAPINE BOXED WARNINGS: per PDR    

      Children, suicidal ideation

      Children, suicidal ideation Mirtazapine is not FDA-approved for the treatment of depression in adolescents or children; safety and efficacy have not been established. Two manufacturer-sponsored, randomized, double-blind, placebo-controlled clinical trials in pediatric patients 7 to 18 years of age with major depressive disorder (n = 259) failed to demonstrate significant differences between mirtazapine and placebo with regard to the primary endpoint and all secondary endpoints. In October 2004, the FDA directed manufacturers of all antidepressants to add a boxed warning to their product labels detailing the risk of suicide in pediatric patients. The risk of suicidality for these drugs was identified in a pooled analysis of 24 placebo-controlled trials (n = 4,400) lasting up to 16 weeks in pediatric patients with major depressive disorder (MDD), obsessive compulsive disorder (OCD), or other psychiatric disorders. The analysis showed a greater risk of suicidality during the first few months of treatment in those receiving antidepressants. The average risk of such events on drug was 4% and 2% for placebo; however, no suicides occurred in these trials. Pooled analysis of short-term clinical trials during early phase treatment with antidepressants in young adults (18 to 24 years) also showed an increased risk of suicidal thinking and behavior. The clinical need for an antidepressant in pediatrics or young adults for any use must be weighed against the risk of increased suicidality; patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior, particularly within the first few months of starting therapy or during dose changes. It is unknown if the suicidality risk in children or young adults extends to longer-term therapy. The possibility of a suicide attempt is inherent in patients with depressive symptoms, whether these occur in primary depression or in association with another primary disorder. All patients with a history of suicidal ideation or behaviors and those with a prominence of suicidal ideation prior to treatment should be closely monitored during treatment with mirtazapine. In patients who exhibit worsening of depression or suicidality, a decision should be made to change or discontinue treatment. If discontinuing, the medication should be tapered as rapidly as possible, but with recognition that abrupt discontinuation can also cause adverse symptoms. All antidepressants should be prescribed in the smallest quantity consistent with good patient management to reduce the risk of overdose.*

      top of page

      MIRTAZAPINE TECHNICAL DATA AND REFERENCES

       

      According to the FDA 

      Nervous System: frequent: hypesthesia, apathy, depression, hypokinesia, vertigo, twitching, agitation, anxiety, amnesia, hyperkinesia, paresthesia; infrequent: ataxia, delirium, delusions, depersonalization, dyskinesia, extrapyramidal syndrome, libido increased, coordination abnormal, dysarthria, hallucinations, manic reaction, neurosis, dystonia, hostility, reflexes increased, emotional lability, euphoria, paranoid reaction; rare: aphasia, nystagmus, akathisia, stupor, dementia, diplopia, drug dependence, paralysis, grand mal convulsion, hypotonia, myoclonus, psychotic depression, withdrawal syndrome*


      DISCLAIMER:

      *While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice. 

      *The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness. 

      *The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with Your physician to help you with your drug withdrawal process and with his or her consent throughout. 

      *This program is not meant to cure or prevent any disease or illness. 

      *Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More..